IC
IEQ Capital Portfolio holdings
AUM
$16.3B
1-Year Return
39.51%
This Quarter Return
+25.09%
1 Year Return
+39.51%
3 Year Return
+152.4%
5 Year Return
+193.99%
10 Year Return
–
AUM
$16.3B
AUM Growth
+$3.77B
(+30%)
Cap. Flow
+$1.26B
Cap. Flow
% of AUM
7.69%
Top 10 Holdings %
Top 10 Hldgs %
35.29%
Holding
2,029
New
422
Increased
852
Reduced
463
Closed
222
Top Buys
| 1 |
NVIDIA
NVDA
|
+$131M |
| 2 |
Upbound Group
UPBD
|
+$95.4M |
| 3 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$75.2M |
| 4 |
Vanguard Total International Stock ETF
VXUS
|
+$51.3M |
| 5 |
Arista Networks
ANET
|
+$35.5M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$128M |
| 2 |
Apollo Global Management
APO
|
+$70.2M |
| 3 |
Carvana
CVNA
|
+$59.1M |
| 4 |
PDX
PIMCO Dynamic Income Strategy Fund
PDX
|
+$51.3M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$45.8M |
Sector Composition
| 1 | Technology | 24.35% |
| 2 | Communication Services | 20.35% |
| 3 | Financials | 9.77% |
| 4 | Consumer Discretionary | 8% |
| 5 | Healthcare | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Hain Celestial
HAIN
$182M
| $112K | ﹤0.01% |
73,968
+32,070
| +77% | +$48.7K |
|
1702
Tenaya Therapeutics
TNYA
$210M
| $112K | ﹤0.01% |
183,452
+16,132
| +10% | +$9.86K |
|
1703
Nuveen Preferred & Income Opportunities Fund
JPC
$2.64B
| $111K | ﹤0.01% |
13,843
-988
| -7% | -$7.92K |
|
1704
Future Fuel
FF
$170M
| $107K | ﹤0.01% |
27,627
-11,773
| -30% | -$45.7K |
|
|
IGR
1705
CBRE Global Real Estate Income Fund
IGR
$766M
| $107K | ﹤0.01% |
20,141
-1,301
| -6% | -$6.88K |
|
1706
Critical Metals Corp
CRML
$559M
| $106K | ﹤0.01% |
+29,612
| New | +$106K |
|
1707
SES AI
SES
$413M
| $105K | ﹤0.01% |
118,068
-27,860
| -19% | -$24.7K |
|
1708
AGNC Investment
AGNC
$10.7B
| $105K | ﹤0.01% |
11,399
-3,749
| -25% | -$34.5K |
|
1709
Treace Medical Concepts
TMCI
$443M
| $104K | ﹤0.01% |
17,703
+4,480
| +34% | +$26.3K |
|
1710
JELD-WEN Holding
JELD
$537M
| $104K | ﹤0.01% |
+26,457
| New | +$104K |
|
|
GOGL
1711
DELISTED
Golden Ocean Group
GOGL
| $103K | ﹤0.01% |
+14,045
| New | +$103K |
|
1712
Quad
QUAD
$327M
| $101K | ﹤0.01% |
17,794
+840
| +5% | +$4.75K |
|
1713
Eletrobras Common Shares
EBR
$19B
| $100K | ﹤0.01% |
+13,526
| New | +$100K |
|
1714
Zentalis Pharmaceuticals
ZNTL
$108M
| $100K | ﹤0.01% |
86,300
-7,620
| -8% | -$8.84K |
|
1715
Coty
COTY
$3.53B
| $99K | ﹤0.01% |
21,300
-216,532
| -91% | -$1.01M |
|
1716
Vale
VALE
$44.7B
| $98.3K | ﹤0.01% |
+10,127
| New | +$98.3K |
|
1717
Ambac
AMBC
$414M
| $97K | ﹤0.01% |
+13,667
| New | +$97K |
|
1718
Rocket Pharmaceuticals
RCKT
$344M
| $95.7K | ﹤0.01% |
39,052
+14,777
| +61% | +$36.2K |
|
1719
American Vanguard Corp
AVD
$153M
| $94.9K | ﹤0.01% |
24,206
+7,052
| +41% | +$27.6K |
|
1720
Nuveen California Municipal Value Fund
NCA
$289M
| $92K | ﹤0.01% |
+10,604
| New | +$92K |
|
1721
Smith & Wesson
SWBI
$404M
| $91.5K | ﹤0.01% |
+10,537
| New | +$91.5K |
|
1722
Cipher Mining
CIFR
$3.91B
| $89K | ﹤0.01% |
+18,610
| New | +$89K |
|
1723
Prime Medicine
PRME
$693M
| $88.5K | ﹤0.01% |
35,830
+948
| +3% | +$2.34K |
|
1724
Black Diamond Therapeutics
BDTX
$182M
| $88.2K | ﹤0.01% |
+35,545
| New | +$88.2K |
|
1725
Sutro Biopharma
STRO
$81.3M
| $88K | ﹤0.01% |
123,319
+48,253
| +64% | +$34.4K |
|